Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 70/100

Viatris to Participate in the Jefferies London Healthcare Conference Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Jefferies London Healthcare Conference...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) has announced its participation in the Jefferies London Healthcare Conference slated for November 15, 2023. Key executives, including CEO Scott A. Smith, will represent the company in a scheduled fireside chat. Interested investors can access a live webcast during the event, with an archived version available afterwards. This approach reflects Viatris’ commitment to communication and engagement with its stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in the Jefferies London Healthcare Conference indicates engagement with industry leaders.
  • CEO and key executives will be showcasing the company's initiatives, promoting transparency.
  • Live webcast of the event enhances accessibility for investors and stakeholders.

Full Press Release Details

PITTSBURGH , Nov. 14, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ), a global healthcare company, today announced the company will participate in the Jefferies London Healthcare Conference in London, UK on Wednesday, November 15, 2023 . Chief Executive Officer Scott A. Smith , President Rajiv Malik , and Chief Financial Officer Sanjeev Narula will represent the Company in a fireside chat scheduled at 4:30 a.m. ET / 9:30 a.m. GMT .
Interested parties can access a live webcast of the event at investor.viatris.com . An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris Viatris Inc. (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life's moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on Twitter at @ViatrisInc , LinkedIn , Instagram and YouTube .
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When is Viatris participating in the Jefferies London Conference?

Viatris will participate in the Jefferies London Healthcare Conference on November 15, 2023.

Who will represent Viatris at the conference?

CEO Scott A. Smith, President Rajiv Malik, and CFO Sanjeev Narula will represent Viatris.

How can I watch the Viatris conference live?

The live webcast can be accessed at investor.viatris.com.

What is Viatris Inc.'s mission?

Viatris aims to empower people worldwide to live healthier at every life stage.

Where is Viatris headquartered?

Viatris is headquartered in the United States, with global centers in Pittsburgh, Shanghai, and Hyderabad.

Last updated: Nov 14, 2023